![Carol A. Baum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Carol A.
Baum worked as a Marketing Director at Aventis Pharmaceuticals, Inc. She then worked as Vice President-Marketing at Neurocrine Biosciences, Inc. from 2003 to 2008.
After that, she worked as Vice President-Commercialization at Orexigen Therapeutics, Inc. Ms. Baum received an undergraduate degree from The University of Colorado and an MBA from Webster University.
Anciens postes connus de Carol A. Baum
Sociétés | Poste | Fin |
---|---|---|
NEUROCRINE BIOSCIENCES, INC. | Sales & Marketing | 01/02/2008 |
OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Sales & Marketing | - |
Formation de Carol A. Baum
The University of Colorado | Undergraduate Degree |
Webster University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Orexigen Therapeutics, Inc.
![]() Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |